Urologic Diseases  >>  ciprofloxacin (Q3939)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ciprofloxacin (Q3939) / Bayer, Novartis
EMERON, NCT00668122: Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections

Completed
3
212
Europe
Cipro XR (Ciprofloxacin, BAYQ3939), Cipro IR (Ciprofloxacin, BAYQ3939)
Bayer
Urinary Tract Infection
 
01/06

Download Options